NCT Number: NCT00046449
Prevention of Seasonal Affective Disorder
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Study Site, Edmonton, Alberta, Canada
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Patient must meet these criteria in order to be eligible for this study.)
- Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.
Exclusion criteria
(Patient cannot meet these criteria in order to be eligible for this study.)
- Patient has a current or past history of seizure disorder or brain injury.
- Patient has a history or current diagnosis of anorexia nervousa or bulimia.
- Patient has recurrent summer depression more frequently than winter depression.
- Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
- Patient has initiated psychotherapy within the last 3 months.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
GlaxoSmithKline
Industry
Registry information
Important dates
- Study start
- 2002
- Primary completion
- 2003
- Study completion
- 2003
- First posted
- Oct 2, 2002
- Registry last updated
- Jun 4, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence
NCT01714050
Depressive Disorder, Depressive Disorder, Major
Burlington, Vermont, United States
View Trial DetailsTranscranial Bright Light Therapy in Seasonal Affective Disorder (SAD)
NCT01784705
Depressive Disorder, Mental Disorders
Oulu, Finland
View Trial DetailsVirtual Reality Digital Therapeutics for Seasonal Affective Disorder
NCT07161570
Depressive Disorder, Mental Disorders
View Trial DetailsOptimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy
NCT03691792
Depressive Disorder, Mental Disorders
Burlington, Vermont, United States
View Trial Details